Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


April 21, 2015 7:46 PM ET

Pharmaceuticals

Company Overview of OSI Pharmaceuticals Inc.

Company Overview

OSI Pharmaceuticals Inc. offers oncology drug discovery and translational research services which includes discovery of molecular targeted therapies. The company offers Tarceva, which treats non-small cell lung cancer. It develops OSI-906, a small-molecule and dual kinase inhibitor of insulin-like growth factor-1 receptor and insulin receptor for lung and ovarian cancers. The company develops OSI-027, a mammalian target of rapamycin kinase inhibitor that inhibits the kinase activity associated with the TORC1 and TORC2 complexes of mTOR. The company was formerly known as Oncogene Science Inc. and changed its name to OSI Pharmaceuticals Inc. in October 1997. The company was founded in 1983 and...

1 Bioscience Park Drive

Farmingdale, NY 11735

United States

Founded in 1983

512 Employees

Phone:

631-962-0600

Fax:

631-845-5671

Key Executives for OSI Pharmaceuticals Inc.

Executive Vice President and President of Pharmaceutical Business
Age: 52
Senior Vice President, Secretary and General Counsel
Age: 51
Interim Head of Oncology Development
Age: 57
Senior Vice President of Research and Development Diabetes & Obestity
Age: 48
Vice President of Clinical Research
Age: 61
Compensation as of Fiscal Year 2014.

OSI Pharmaceuticals Inc. Key Developments

OSI Pharmaceuticals Inc. Lays Off 115 Local Employees

OSI Pharmaceuticals Inc. announced that it is shuttering its remaining facility in the Long Island region and laying off all 115 of its local employees. The company said that it was closing the facility, located on the campus of Farmingdale State College. Most employees were dismissed immediately; a handful will stay to close the labs over the next four months. The workers will receive severances and continue to be paid for 90 days in accordance with state law. The closure is part of a global consolidation at Astellas, which is also shuttering facilities in Silicon Valley and suburban Chicago, cutting a total of 200 jobs.

Similar Private Companies By Industry

Company Name Region
Tummy Company, Inc. United States
Innophos Nutrition, Inc. United States
Pagoda Pharma Group, Inc. United States
Froptix Corporation United States
Thrombolytic Science International, LLC United States

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact OSI Pharmaceuticals Inc., please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.